Bernard Iung
- Cardiac Valve Diseases and Treatments
- Infective Endocarditis Diagnosis and Management
- Cardiac Structural Anomalies and Repair
- Cardiac Imaging and Diagnostics
- Atrial Fibrillation Management and Outcomes
- Cardiovascular Function and Risk Factors
- Aortic Disease and Treatment Approaches
- Cardiac pacing and defibrillation studies
- Cardiac, Anesthesia and Surgical Outcomes
- Cardiac Arrhythmias and Treatments
- Antimicrobial Resistance in Staphylococcus
- Cardiovascular Issues in Pregnancy
- Streptococcal Infections and Treatments
- Coronary Interventions and Diagnostics
- Orthopedic Infections and Treatments
- Congenital Heart Disease Studies
- Venous Thromboembolism Diagnosis and Management
- Antiplatelet Therapy and Cardiovascular Diseases
- Acute Myocardial Infarction Research
- Pericarditis and Cardiac Tamponade
- Pulmonary Hypertension Research and Treatments
- Aortic aneurysm repair treatments
- Health Systems, Economic Evaluations, Quality of Life
- Infectious Aortic and Vascular Conditions
- Cardiac and Coronary Surgery Techniques
Laboratoire de Recherche Vasculaire Translationnelle
2016-2025
Inserm
2016-2025
Hôpital Bichat-Claude-Bernard
2016-2025
Assistance Publique – Hôpitaux de Paris
2016-2025
Université Claude Bernard Lyon 1
2016-2025
Sorbonne Paris Cité
2012-2025
Université Paris Cité
2016-2025
Hôpital Pontchaillou
2024
Hôpital Beaujon
2023-2024
Nord University
2024
2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation The Task Force European Society Cardiology (ESC)
Supplementary Table 9, column 'Edoxaban', row 'eGFR category', '95 mL/min' (page 15). The cell should be coloured green instead of yellow. It also read 60 mginstead mg (use with caution in 'supranormal' renal function).In the above-indicated cell, a footnote has been added to state: Edoxaban used patients high creatinine clearance only after careful evaluation individual thromboembolic and bleeding risk.Supplementary 'Dose reduction selected patients' 16). reduced 30 once daily if any...
The ESC/EAS Guidelines represent the views of ESC and EAS, were produced after careful consideration scientific medical knowledge, evidence available at time their publication.The EAS is not responsible in event any contradiction, discrepancy, and/or ambiguity between other official recommendations or guidelines issued by relevant public health authorities, particular relation to good use healthcare therapeutic strategies.Health professionals are encouraged take fully into account when...
ESC guidelines for the diagnosis and treatment of acute chronic heart failure 2012 : The Task Force Diagnosis Treatment Acute Chronic Heart Failure European Society Cardiology. Developed in collaboration with Association (HFA)
Coronary artery disease (CAD) is a pathological process characterized by atherosclerotic plaque accumulation in the epicardial arteries, whether obstructive or non-obstructive. This can be modified lifestyle adjustments, pharmacological therapies, and invasive interventions designed to achieve stabilization regression. The have long, stable periods but also become unstable at any time, typically due an acute atherothrombotic event caused rupture erosion. However, chronic, most often...
Mathematical support for phonocardiographic signal processing has been developed based on a mathematical model in the form of periodically correlated stochastic process and component method.On basis support, algorithmic software was Matlab environment automated systems computer diagnostics functional state valves human heart when mitral insufficiency is detected.
The ESC Guidelines represent the views of and were produced after careful consideration scientific medical knowledge evidence available at time their publication.The is not responsible in event any contradiction, discrepancy and/or ambiguity between other official recommendations or guidelines issued by relevant public health authorities, particular relation to good use healthcare therapeutic strategies.Health professionals are encouraged take fully into account when exercising clinical...
The ESC Guidelines represent the views of and were produced after careful consideration scientific medical knowledge evidence available at time their dating.The is not responsible in event any contradiction, discrepancy and/or ambiguity between other official recommendations or guidelines issued by relevant public health authorities, particular relation to good use care therapeutic strategies.Health professionals are encouraged take fully into account when exercising clinical judgment, as...
Guidelines •
Guidelines summarize and evaluate available evidence with the aim of assisting health professionals in proposing best management strategies for an individual patient a given condition. their recommendations should facilitate decision making daily practice. However, final decisions concerning must be made by responsible professional(s) consultation caregiver as appropriate.
of the individual patients, in consultation with that patient, and where appropriate necessary patient's guardian or carer.It is also health professional's responsibility to verify rules regulations applicable drugs devices at time prescription.
The ESC/EACTS Guidelines represent the views of ESC and EACTS were arrived at after careful consideration available evidence time they written.Health professionals are encouraged to take them fully into account when exercising their clinical judgement.The guidelines do not, however, override individual responsibility health make appropriate decisions in circumstances patients, consultation with that patient and, where necessary, patient's guardian or carer.It is also professional's verify...
Aims To identify the characteristics, treatment, and outcomes of contemporary patients with valvular heart disease (VHD) in Europe, to examine adherence guidelines.
The ESC Guidelines represent the views of and were produced after careful consideration scientific medical knowledge evidence available at time their publication.The is not responsible in event any contradiction, discrepancy and/or ambiguity between other official recommendations or guidelines issued by relevant public health authorities, particular relation to good use healthcare therapeutic strategies.Health professionals are encouraged take fully into account when exercising clinical...
The ESC Guidelines represent the views of and were produced after careful consideration scientific medical knowledge evidence available at time their publication.The is not responsible in event any contradiction, discrepancy and/or ambiguity between other official recommendations or guidelines issued by relevant public health authorities, particular relation to good use healthcare therapeutic strategies.Health professionals are encouraged take fully into account when exercising clinical...
Table 1. Classes of recommendation Table 2. Levels evidence Table 3. Estimated fetal and maternal effective doses for various diagnostic interventional radiology procedures Table 4. Predictors cardiovascular events risk score from the CARPREG study Table 5. identified in congential heart diseases ZAHARA Khairy 6. Modified WHO classification risk: principles Table 7. application Table 8. Maternal predictors neonatal women with disease Table 9. General recommendations Table 10....
The ESC Guidelines represent the views of and were produced after careful consideration scientific medical knowledge, evidence available at time their publication.The is not responsible in event any contradiction, discrepancy, and/or ambiguity between other official recommendations or guidelines issued by relevant public health authorities, particular relation to good use healthcare therapeutic strategies.Health professionals are encouraged take fully into account when exercising clinical...